Jinqi Medical Acquires Singapore's SHG Group, Unveiling Global Strategy in Reproductive Healthcare

VCBeat (WeChat ID: vcbeat) has learned that on September 12, Jinqi Medical signed a controlling interest agreement with Singapore’s Sincere Healthcare Group (hereinafter referred to as “SHG”) at Marina Bay Sands in Singapore. This cross-border merger and acquisition marks a significant step for Jinqi Medical in building its global reproductive health industry footprint, and represents a major move following the company’s recent completion of a financing round worth hundreds of millions of yuan.

Jinqi Medical Acquires Singapore’s SHG Group (Image provided by the company)

Ms. Zhang Jinxia, Chairwoman of Jinqi Medical, stated that the acquisition of Singapore’s SHG Group represents a strategic layout for Jinqi Medical to build a global reproductive health industry. Jinqi Medical is committed to integrating high-quality medical resources from both domestic and international markets, providing more and better medical services to families facing infertility, and turning their dream of having a baby into reality.

Jenny Bi, CEO of SHG Group, stated that SHG boasts a professional medical team composed of experienced fertility specialists, embryologists, nurses, and health experts. Meanwhile, Jinqi possesses a comprehensive service system, a reserve of specialized professionals, and extensive industry-wide resources. The partnership with Jinqi Medical represents a strategic alliance between two industry leaders, fostering strong confidence in the future development of “Jinqi·SHG.”

According to incomplete statistics from health authorities, approved assisted reproductive technology (ART) institutions cumulatively performed 1.2 million ART procedures in 2017. However, relative to the more than 50 million patients suffering from infertility, the market remains in a state of severe supply-demand imbalance.

With over 40 years of development, assisted reproductive technology has become increasingly mature, and more than 8 million IVF babies have been born and are growing up healthy worldwide. Public awareness and acceptance of in vitro fertilization (IVF) continue to rise, making assisted reproduction the “mainstream choice” for treating infertility.

In recent years, the Chinese government has continuously introduced favorable policies, including the full implementation of the two-child policy and a gradual relaxation of fertility restrictions. These multifaceted positive factors indicate that the assisted reproductive technology (ART) market is poised for explosive growth, with a market size reaching hundreds of billions of yuan.

Through this collaboration, we hope that the business integration of “Jinqi · SHG” will bring more opportunities to the infertility market and benefit more families struggling with infertility. “Healthier mothers, more hopeful fathers, and innocent smiles carrying forward dreams.”

Sincere Healthcare Group, established in 2011 and headquartered at the Novena Specialist Center in Singapore, is dedicated to providing high-quality medical care and personalized health services for both women and men. In Singapore, it operates two IVF centers, one specialist center, one men’s health center, one andrology laboratory, and one vascular surgery and interventional therapy center; in Malaysia, it has one IVF center; and in China, it operates the Xiamen Xinjiaxin Outpatient Clinic, the Xinjiaxin Gynecology Outpatient Clinic, and the Chengdu Baihui Xinkang General Practice Outpatient Clinic.

Its professional medical team is led by Professor Soon-Chye Ng, known as the “Father of IVF in Asia.” Professor Soon-Chye Ng is a Member of the Royal College of Obstetricians and Gynaecologists (RCOG) in London and a Member of the Asia and Oceania Federation of Obstetrics and Gynaecology. He previously served as Chairman of the Department of Obstetrics and Gynaecology at the National University of Singapore and as Chairman of the Obstetrics and Gynaecology Medical Research Committee of the NUS Graduate School. In May 1983, Professor Soon-Chye Ng successfully delivered Southeast Asia’s first test-tube baby; in 1988, he achieved the world’s first successful birth via Subzonal Injection (SUZI); and in 1993, he facilitated the birth of Asia’s first baby conceived through Intracytoplasmic Sperm Injection (ICSI).